TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Otsuka Pharma Scandinavia AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
30,178
|
28,909
|
27,874 |
Financial expenses |
0
|
3
|
20 |
Earnings before taxes |
821
|
1,058
|
902 |
EBITDA |
800
|
1,091
|
967 |
Total assets |
11,890
|
10,903
|
10,100 |
Current assets |
11,828
|
10,857
|
10,046 |
Current liabilities |
7,472
|
6,300
|
5,274 |
Equity capital |
4,417
|
4,603
|
4,826 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
38
|
35
|
36 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
37.1%
|
42.2%
|
47.8% |
Turnover per employee |
794
|
826
|
774 |
Profit as a percentage of turnover |
2.7%
|
3.7%
|
3.2% |
Return on assets (ROA) |
6.9%
|
9.7%
|
9.1% |
Current ratio |
158.3%
|
172.3%
|
190.5% |
Return on equity (ROE) |
18.6%
|
23.0%
|
18.7% |
Change turnover |
1,185
|
3,293
|
-1,339 |
Change turnover % |
4%
|
13%
|
-5% |
Chg. No. of employees |
3
|
-1
|
-6 |
Chg. No. of employees % |
9%
|
-3%
|
-14% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.